A multicenter retrospective analysis of clinical outcomes, toxicities, and patterns of use in institutions utilizing commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive B-cell lymphomas Meeting Abstract
| Authors: | Riedell, P. A.; Walling, C.; Nastoupil, L. J.; Pennisi, M.; Maziarz, R. T.; McGuirk, J. P.; Oluwole, O. O.; Bachanova, V.; Hwang, W. T.; Schuster, S. J.; Perales, M. A.; Bishop, M. R.; Porter, D. L. |
| Abstract Title: | A multicenter retrospective analysis of clinical outcomes, toxicities, and patterns of use in institutions utilizing commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive B-cell lymphomas |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577160402151 |
| DOI: | 10.1182/blood-2019-127490 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1599 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
